Ucb Biopharma Srl

This study tests an investigational drug called bimekizumab against a placebo in 300 adults with palmoplantar pustulosis (PPP), a chronic skin condition causing painful pustules on the palms and soles. The main goal is to see if bimekizumab can clear or nearly clear the skin lesi…

This study looks at the long-term safety of the drug brivaracetam in children and teenagers with absence epilepsy (brief staring spells). About 120 participants who were in earlier studies will take the drug and be monitored for side effects. The goal is to see if the drug is saf…

This study tests a new drug called bimekizumab against an existing one (ustekinumab) for children and teens aged 6 to 17 with moderate to severe plaque psoriasis. The goal is to see if bimekizumab clears skin better at 16 weeks. About 168 participants will receive injections, and…

This study tests a drug called rozanolixizumab in 12 children aged 2 to 17 with moderate to severe generalized myasthenia gravis, a condition that causes muscle weakness. The main goal is to see if the drug is safe and tolerable. Participants receive the drug as a shot under the …

This study tests a new medication, galvokimig, in 160 adults with moderate-to-severe atopic dermatitis (eczema). Participants receive either the drug or a placebo to see if it improves skin symptoms like redness and itching. The main goal is to measure how many people achieve at …

This study tests the drug rozanolixizumab in 40 Chinese adults with generalized myasthenia gravis, a condition that causes muscle weakness. The main goal is to see if the drug improves daily activities after one treatment cycle. Participants receive the drug and are monitored for…

This study tests a fast-acting inhaled medication (Staccato alprazolam) to see if it can stop a prolonged seizure within 90 seconds and prevent it from coming back for at least 2 hours. The trial involves 350 people aged 12 and older who have stereotypical prolonged seizures. Par…